re: Ann: Interim Financial Report for the hal... Well lets see what the market thinks this morning, obviously a lot of people have no idea about an up and coming company is all about.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress